Parents' Experiences With and Preferences for Receiving Information About Tumor Genomic Sequencing: Findings From a Qualitative Study and Implications for Practice For a 2-year overall survival end ...

Multigene tests are an integral component of new policy initiatives such as the US National Institutes of Health (NIH) Precision Medicine Initiative and the US National Cancer Institute Cancer ...

Patients with non–small cell lung cancer (NSCLC) who tested positive for driver gene alteration had longer overall survival when given targeted therapy. Multigene testing should be utilized more to ...

HELOISE: Phase IIIb Randomized Multicenter Study Comparing Standard-of-Care and Higher-Dose Trastuzumab Regimens Combined With Chemotherapy as First-Line Therapy in Patients With Human Epidermal ...

This transcript has been edited for clarity. Hello. I'm Dr Maurie Markman, from City of Hope. I'd like to speak for the next few minutes on a very interesting modeling study that was recently ...

Current guidelines for genetic testing in women with breast cancer are based on established family history or clinical guidelines but miss approximately 50% of carriers who fall below the clinical ...

"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this journey through a disease state contains ...

The paper is entitled, “ Utilization and outcomes of multigene panel testing in patients with pancreatic ductal adenocarcinoma.” This analysis was looking specifically at pancreas cancer and data that ...

A large US study showed population-based multigene testing might be a cost-effective way to identify women at risk for breast and ovarian cancer, potentially preventing more cases but raising concerns ...

Gene-expression profiling of tumors may soon become a routine part of how an oncologist decides on the best way to treat an expanding number of malignancies. While many technologies are in early ...

TYE agar plates (1.0% tryptone, 0.5% yeast extract, 0.8% NaCl, 1.5% agar) Low-salt TYE medium (1.0% tryptone, 0.5% yeast extract, 0.5% NaCl) and agar plates (1.0% ...

Using a gene signature technique to tailor chemotherapy for patients with early triple negative breast cancer shows promise as a way to improve disease-free survival, finds a clinical trial published ...